Early tocilizumab treatment in ICU tied to lower COVID-19 mortality
10 Feb 2021
byRoshini Claire Anthony
Critically ill patients who received tocilizumab within 2 days of admission to the intensive care unit (ICU) for COVID-19 had a lower risk of mortality than those not treated with tocilizumab, according to a recent study.
Early tocilizumab treatment in ICU tied to lower COVID-19 mortality
10 Feb 2021
